Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease c syndrome
Comorbidity C0018799|heart disease
Sentences 24
PubMedID- 22548293 Metabolic syndrome is associated with coronary heart disease (chd) and new-onset diabetes after kidney transplant (nodat).
PubMedID- 21153653 Obesity does not appear to be an independent predictor for the 10-year risk of coronary heart disease events in patients without metabolic syndrome treated with second-generation antipsychotics.
PubMedID- 24793349 Background and objectives: to evaluate the risk of coronary heart disease (chd) associated with metabolic syndrome (mets) and its individual components in a representative sample of diabetic and nondiabetic iranians.
PubMedID- 21151616 Unlike class i and iia hdacs, class iii hdacs play an important role in regulating oxidative stress in heart diseases with metabolic syndromes.
PubMedID- 22131755 [26] furthermore, insulin-resistant patients, with and without type 2 diabetes, are at an increased risk for developing metabolic syndrome, a major cause of heart disease, hypertension and dyslipidemia.
PubMedID- 26274823 The relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function--an occupational cohort-based study.
PubMedID- 20940070 Objective: we examined the risk of cardiovascular disease, stroke, ischaemic heart disease, and diabetes with the metabolic syndrome according to the new harmonised definition and its components using a national longitudinal data set from an asian population.
PubMedID- 19969373 We sought to determine whether psychological factors were associated with a greater prevalence of the metabolic syndrome in patients with coronary heart disease, and the extent to which such an association may be explained by socioeconomic status, health behaviors, and biological mediators.
PubMedID- 22355990 Frequency of metabolic syndrome in patients with ischaemic heart disease.
PubMedID- 26401840 Correction: the relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function - an occupational cohort-based study.
PubMedID- 21139493 Procollagen iii n-terminal peptide predicts short-term prognosis and cardiac remodeling in coronary heart disease patients with metabolic syndrome.
PubMedID- 26413101 Genetic syndromes associated with congenital heart disease.
PubMedID- 22906266 Associations between coronary heart disease and individual components of the metabolic syndrome according to glucose tolerance status.
PubMedID- 21636030 We also discuss that a healthy lifestyle is essential for preventing and treating chronic kidney disease and coronary heart disease seen in patients with metabolic syndrome.
PubMedID- 21186101 This study evaluates the association of incident clinical coronary heart disease with metabolic syndrome and each of its individual defining components in a sample of spanish working males.
PubMedID- 24174878 After an additional follow-up period of 4.9 years, coronary artery calcium progression was able to predict coronary heart disease events in patients with metabolic syndrome and without type 2 diabetes, as well as in those with type 2 diabetes.
PubMedID- 25018941 The increased risk of coronary heart disease associated with nephrotic syndrome.
PubMedID- 23479983 [quality of life in patients with coronary heart disease associated with metabolic syndrome: results of factor analysis].
PubMedID- 20826918 The aim of the present study was to determine the associations between platelet morphology markers and hemoglobin a1c (hba(1c)), fasting glucose (fg), hypertension and coronary heart disease (chd) in patients with myelodysplastic syndromes (mds) and dm, in patients with dm and in controls.
PubMedID- 23819342 [comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome].
PubMedID- 23091851 Aim: to define the pharmacogenetic features of the effect of metformin in coronary heart disease (chd) patients with metabolic syndrome (ms) or type 2 diabetes mellitus (t2dm), by taking into consideration ppar-gamma2 pro1 2ala polymorphism.
PubMedID- 23251156 The increased risk of coronary heart disease in patients with the metabolic syndrome suggests that the insulin-resistant state is atherogenic without concomitant elevations in plasma glucose and glycosylated hemoglobin [26, 27].
PubMedID- 19935427 The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease.
PubMedID- 22780328 Introduction: excessive abdominal obesity along with other risk factors results in the metabolic syndrome, which can lead to heart disease, type-2 diabetes, and death.

Page: 1